Method and system for tailored anti-cancer therapy based on the information of genomic sequence variant and survival of cancer patient

摘要

The present invention relates to a method and system for customized drug selection using cancer genome sequence variation and patient survival information. More specifically, the present invention relates to a method and system for selecting a drug, To a method and system for drug selection. A method and system for customized chemotherapy using the cancer mutation and patient survival information of the present invention or evaluation of the invasion or metastasis ability of cancer cells or tissues can be used for the cancer survival gene pair derived from cancer genome sequence mutation and cancer survival and metastasis information Through the mutation analysis, it is possible to effectively select chemotherapeutic drugs with good therapeutic effect and good prognosis for individual, and it is highly reliable and can provide relevant information quickly and simply.